_id

690db26bccc777a4e85d0c68

Ticker

ATHE

Name

Alterity Therapeutics Ltd

Exchange

NASDAQ

Address

350 Collins Street, Melbourne, VIC, Australia, 3000

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://alteritytherapeutics.com

Description

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.

Last Close

3.42

Volume

24888

Current Price

3.29

Change

-3.801169590643272

Last Updated

2025-11-28T12:30:07.956Z

Image

data:image/webp;base64,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

Ipo Date

2002-09-05T00:00:00.000Z

Market Cap

68515120

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.963

Sentiment Sources

1

Rating

4

Target Price

12

Strong Buy

1

Buy

1

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-06-30

Revenue

3832993

Cost Of Revenue

63924

Gross Profit

3769068

Operating Expenses

10857213

Operating Income

-7088145

Interest Expense

-

Pretax Income

-4906438

Net Income

-4974493

Eps

-0.399000896179171

Dividends Per Share

-

Shares Outstanding

18125694

Income Tax Expense

68055

EBITDA

-7107421

Operating Margin

-184.92454851861194

Total Other Income Expense Net

2181707

Cash

33158642

Short Term Investments

7500000

Receivables

3937607

Inventories

-

Total Current Assets

45871186

Property Plant Equipment

155174

Total Assets

46026360

Payables

538276

Short Term Debt

66912

Long Term Debt

-

Total Liabilities

3623274

Equity

42403086

Depreciation

11445

Change In Working Capital

3440277

Cash From Operations

-2355248

Capital Expenditures

0

Cash From Investing

-7500000

Cash From Financing

25242380

Net Change In Cash

15201642

PE

-

PB

0.967327169772502

ROE

-11.731440961631897

ROA

-10.807921808285514

FCF

-2355248

Fcf Percent

-0.6144670757290712

Piotroski FScore

1

Health Score

34

Deep Value Investing Score

5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.8

Garp Investing Score

4.5

Growth Investing Score

3

Momentum Investing Score

4

Net Net Investing Score

3

Quality Investing Score

2.5

Value Investing Score

4.5

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

3832993

Quarters > 0 > income Statement > cost Of Revenue

63924

Quarters > 0 > income Statement > gross Profit

3769068

Quarters > 0 > income Statement > operating Expenses

10857213

Quarters > 0 > income Statement > operating Income

-7088145

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-4906438

Quarters > 0 > income Statement > net Income

-4974493

Quarters > 0 > income Statement > eps

-0.399000896179171

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

12467373

Quarters > 0 > income Statement > income Tax Expense

68055

Quarters > 0 > income Statement > EBITDA

-7107421

Quarters > 0 > income Statement > operating Margin

-184.92454851861194

Quarters > 0 > income Statement > total Other Income Expense Net

2181707

Quarters > 0 > balance Sheet > cash

33158642

Quarters > 0 > balance Sheet > short Term Investments

7500000

Quarters > 0 > balance Sheet > receivables

3937607

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

45871186

Quarters > 0 > balance Sheet > property Plant Equipment

155174

Quarters > 0 > balance Sheet > total Assets

46026360

Quarters > 0 > balance Sheet > payables

538276

Quarters > 0 > balance Sheet > short Term Debt

66912

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

3623274

Quarters > 0 > balance Sheet > equity

42403086

Quarters > 0 > cash Flow > net Income

-

Quarters > 0 > cash Flow > depreciation

11445

Quarters > 0 > cash Flow > change In Working Capital

3440277

Quarters > 0 > cash Flow > cash From Operations

-2355248

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-7500000

Quarters > 0 > cash Flow > cash From Financing

25242380

Quarters > 0 > cash Flow > net Change In Cash

15201642

Quarters > 0 > ratios > PE

-0.399000896179171

Quarters > 0 > ratios > PB

0.967327169772502

Quarters > 0 > ratios > ROE

-11.731440961631897

Quarters > 0 > ratios > ROA

-10.807921808285514

Quarters > 0 > ratios > FCF

-2355248

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-0.6144670757290712

Quarters > 0 > health Score

34

Quarters > 1 > quarter

2024-12-31

Quarters > 1 > income Statement > revenue

1605925

Quarters > 1 > income Statement > cost Of Revenue

63598

Quarters > 1 > income Statement > gross Profit

1542327

Quarters > 1 > income Statement > operating Expenses

9028468

Quarters > 1 > income Statement > operating Income

-7486141

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-8779260

Quarters > 1 > income Statement > net Income

-7173335

Quarters > 1 > income Statement > eps

-0.810024068098015

Quarters > 1 > income Statement > dividends Per Share

0

Quarters > 1 > income Statement > shares Outstanding

8855706

Quarters > 1 > income Statement > income Tax Expense

-1605925

Quarters > 1 > income Statement > EBITDA

-7525823

Quarters > 1 > income Statement > operating Margin

-466.1575727384529

Quarters > 1 > income Statement > total Other Income Expense Net

-1293119

Quarters > 1 > balance Sheet > cash

4536559

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

5625211

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

10431182

Quarters > 1 > balance Sheet > property Plant Equipment

115751

Quarters > 1 > balance Sheet > total Assets

10546933

Quarters > 1 > balance Sheet > payables

2050847

Quarters > 1 > balance Sheet > short Term Debt

62713

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

2760926

Quarters > 1 > balance Sheet > equity

7786007

Quarters > 1 > cash Flow > net Income

-7173335

Quarters > 1 > cash Flow > depreciation

36295

Quarters > 1 > cash Flow > change In Working Capital

-2009498

Quarters > 1 > cash Flow > cash From Operations

-8359622

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

369319

Quarters > 1 > cash Flow > net Change In Cash

-4746441

Quarters > 1 > ratios > PE

-0.810024068098015

Quarters > 1 > ratios > PB

3.742004436934105

Quarters > 1 > ratios > ROE

-92.13111418985366

Quarters > 1 > ratios > ROA

-68.01346893926414

Quarters > 1 > ratios > FCF

-8359622

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-5.205487180285505

Quarters > 1 > health Score

29

Quarters > 2 > quarter

2024-09-30

Quarters > 2 > income Statement > revenue

802963

Quarters > 2 > income Statement > cost Of Revenue

31799

Quarters > 2 > income Statement > gross Profit

771164

Quarters > 2 > income Statement > operating Expenses

4514235

Quarters > 2 > income Statement > operating Income

-3743071

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-3586668

Quarters > 2 > income Statement > net Income

-3586668

Quarters > 2 > income Statement > eps

-0.4050120905097798

Quarters > 2 > income Statement > dividends Per Share

0

Quarters > 2 > income Statement > shares Outstanding

8855706

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-3762912

Quarters > 2 > income Statement > operating Margin

-466.15734473443985

Quarters > 2 > income Statement > total Other Income Expense Net

156403

Quarters > 2 > balance Sheet > cash

4536559

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

5625211

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

10431182

Quarters > 2 > balance Sheet > property Plant Equipment

115751

Quarters > 2 > balance Sheet > total Assets

10546933

Quarters > 2 > balance Sheet > payables

2050847

Quarters > 2 > balance Sheet > short Term Debt

62713

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

2760926

Quarters > 2 > balance Sheet > equity

7786007

Quarters > 2 > cash Flow > net Income

-3586668

Quarters > 2 > cash Flow > depreciation

36295

Quarters > 2 > cash Flow > change In Working Capital

-1004749

Quarters > 2 > cash Flow > cash From Operations

-4179811

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

149160

Quarters > 2 > cash Flow > net Change In Cash

-

Quarters > 2 > ratios > PE

-0.4050120905097798

Quarters > 2 > ratios > PB

3.742004436934105

Quarters > 2 > ratios > ROE

-46.06556351670375

Quarters > 2 > ratios > ROA

-34.006739210346744

Quarters > 2 > ratios > FCF

-4179811

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-5.205483938861442

Quarters > 2 > health Score

29

Quarters > 3 > quarter

2024-06-30

Quarters > 3 > income Statement > revenue

2118561

Quarters > 3 > income Statement > cost Of Revenue

73612

Quarters > 3 > income Statement > gross Profit

2044949

Quarters > 3 > income Statement > operating Expenses

14984406

Quarters > 3 > income Statement > operating Income

-12983181

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-14688754

Quarters > 3 > income Statement > net Income

-12616281

Quarters > 3 > income Statement > eps

-1.2000000570691185

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

10513567

Quarters > 3 > income Statement > income Tax Expense

-2072473

Quarters > 3 > income Statement > EBITDA

-14615141

Quarters > 3 > income Statement > operating Margin

-612.8301710453463

Quarters > 3 > income Statement > total Other Income Expense Net

-1705573

Quarters > 3 > balance Sheet > cash

12638885

Quarters > 3 > balance Sheet > short Term Investments

0

Quarters > 3 > balance Sheet > receivables

4041675

Quarters > 3 > balance Sheet > inventories

-22389

Quarters > 3 > balance Sheet > total Current Assets

19036860

Quarters > 3 > balance Sheet > property Plant Equipment

186883

Quarters > 3 > balance Sheet > total Assets

19223743

Quarters > 3 > balance Sheet > payables

581137

Quarters > 3 > balance Sheet > short Term Debt

107131

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

5425686

Quarters > 3 > balance Sheet > equity

13798057

Quarters > 3 > cash Flow > net Income

-12616281

Quarters > 3 > cash Flow > depreciation

73612

Quarters > 3 > cash Flow > change In Working Capital

3138193

Quarters > 3 > cash Flow > cash From Operations

-8110884

Quarters > 3 > cash Flow > capital Expenditures

278

Quarters > 3 > cash Flow > cash From Investing

-722

Quarters > 3 > cash Flow > cash From Financing

8165945

Quarters > 3 > cash Flow > net Change In Cash

318459

Quarters > 3 > ratios > PE

-1.2000000570691185

Quarters > 3 > ratios > PB

2.506848277985806

Quarters > 3 > ratios > ROE

-91.43519989807261

Quarters > 3 > ratios > ROA

-65.62863954225772

Quarters > 3 > ratios > FCF

-8111162

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-3.8286185764771465

Quarters > 3 > health Score

35

Valuation > metrics > PE

-0.399000896179171

Valuation > metrics > PB

0.967327169772502

Valuation > final Score

70

Valuation > verdict

3.3% Undervalued

Profitability > metrics > ROE

-11.731440961631897

Profitability > metrics > ROA

-10.844483070483506

Profitability > metrics > Net Margin

-1.2978090489599121

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.08544835628237057

Risk > metrics > Interest Coverage

-3.220445137468122

Risk > final Score

47

Risk > verdict

High

Liquidity > metrics > Current Ratio

75.79658882859542

Liquidity > metrics > Quick Ratio

75.79658882859542

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

42.57995563065895

Prev Valuations > 1

42.57995563065895

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

36

Prev Risks > 1

-25

Prev Risks > 2

-645

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:14:55.424Z